Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Breast Cancer”

323 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 323 results

Early research (Phase 1)Study completedNCT03854903
What this trial is testing

WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor

Who this might be right for
Metastatic Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastHormone Receptor Positive Breast Cancer
Georgetown University 19
Early research (Phase 1)Ended earlyNCT00629876
What this trial is testing

A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.

Who this might be right for
Anemia
Takeda 2
Early research (Phase 1)Study completedNCT01097460
What this trial is testing

MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer

Who this might be right for
Breast Neoplasms
Merrimack Pharmaceuticals 16
Large-scale testing (Phase 3)Looking for participantsNCT07205822
What this trial is testing

Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 100
Early research (Phase 1)Study completedNCT01245205
What this trial is testing

Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerRecurrent Breast Cancer+4 more
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Testing effectiveness (Phase 2)Study completedNCT00063102
What this trial is testing

ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.

Who this might be right for
Breast Cancer
Abbott 40
Not applicableNot Yet RecruitingNCT06438055
What this trial is testing

Clinical Treatment of Refractory Breast Cancer Based on Organoid Drug Sensitivity Results

Who this might be right for
Refractory Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 40
Testing effectiveness (Phase 2)UnknownNCT02587689
What this trial is testing

Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+1 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT02312622
What this trial is testing

Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer

Who this might be right for
Stage IV Non-small Cell Lung Cancer (NSCLC)Recurrent Non-small Cell Lung Cancer (NSCLC)Extensive-stage Small Cell Lung Cancer (SCLC)+3 more
Joel Neal 27
Testing effectiveness (Phase 2)Study completedNCT03950570
What this trial is testing

ORIN1001 in Patients with Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer

Who this might be right for
Advanced Solid TumorMetastatic Breast Cancer
Orinove, Inc. 58
Early research (Phase 1)Study completedNCT00348699
What this trial is testing

AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Male Breast CancerRecurrent Breast CancerRecurrent Ovarian Epithelial Cancer+7 more
National Cancer Institute (NCI) 68
Testing effectiveness (Phase 2)Ended earlyNCT03342417
What this trial is testing

Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients

Who this might be right for
Breast Cancer FemaleOvarian CancerGastric Cancer
ExcellaBio LLC 5
Testing effectiveness (Phase 2)Study completedNCT00051103
What this trial is testing

Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.

Who this might be right for
Metastatic Breast CancerNeoplasms, Breast
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT02834403
What this trial is testing

L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients

Who this might be right for
Metastatic Triple Negative Breast Cancer
The Methodist Hospital Research Institute 37
Early research (Phase 1)Study completedNCT02152943
What this trial is testing

Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients

Who this might be right for
Advanced Malignant Solid NeoplasmEstrogen Receptor PositiveHER2/Neu Positive+10 more
M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT00109993
What this trial is testing

Campath-1H + FK506 and Methylprednisolone for GVHD

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Case Comprehensive Cancer Center 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT04837209
What this trial is testing

Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast Cancer
Massachusetts General Hospital 32
Early research (Phase 1)Study completedNCT00001444
What this trial is testing

A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms

Who this might be right for
Breast CancerLymphomaNeoplasm+1 more
National Cancer Institute (NCI) 51
Not applicableStudy completedNCT03301493
What this trial is testing

Genomic Testing and Resulting Medical Decisions

Who this might be right for
Cancer of Unknown OriginCancer RefractoryCancer of Stomach+12 more
Arbeitsgemeinschaft medikamentoese Tumortherapie 1,500
Load More Results